RayGel-An Alternative for Skin Care During External Beam Radiation
Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
This study is for the patient with breast cancer. To take part in this study, external beam
radiation therapy needs to be part of the treatment plan. Reduced glutathione, an ingredient
of RayGel™, has been helpful in decreasing some radiation therapy side effects to the skin.
Reduced glutathione plays a vital role in both making DNA and cell repair. This study will
measure if RayGel decreases skin reaction in breast cancer patients treated with external
beam radiation therapy.